Rapid Micro Biosystems, Inc RPID
π Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-15 |
| Shares Out. | 49,420,000 |
| Website | rapidmicrobio.com/ β |
| Phone | 13026587581 |
| Employees | 171 |
| Revenue | $8.1M |
| Gross Profit | $1.2M |
| Net Income | -$12.9M |
| Free Cash Flow | -$40.4M |
| Total Assets | $58.5M |
| Total Liabilities | $40.7M |
| Equity | $17.7M |
About Rapid Micro Biosystems, Inc
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
Rapid Micro Biosystems, Inc is a publicly traded company under the ticker symbol RPID on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
10 analysts (2026-09-01)

